Tandem Diabetes Receives CE Mark for Expanded Indications of Insulin Delivery Systems
Tandem Diabetes Care announced receipt of CE mark for expanded indications of its automated insulin delivery systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes.
